Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. - Wikidata - awgldk - TriplyDB

Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666.

Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666.

http://www.wikidata.org/entity/Q33609896

about

Methodological aspects of 99mTc-sestamibi guided biopsy in breast cancer Vision 20/20: Mammographic breast density and its clinical applications Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast Reduction of claustrophobia with short-bore versus open magnetic resonance imaging: a randomized controlled trial.The need for supplemental breast cancer screening modalities: a perspective of population-based breast cancer screening programs in Japan.Building a virtual simulation platform for quasistatic breast ultrasound elastography using open source software: A preliminary investigation Nuclear imaging of the breast: translating achievements in instrumentation into clinical use High-field open versus short-bore magnetic resonance imaging of the spine: a randomized controlled comparison of image quality Correlation of PUV and SUV in the extremities while using PEM as a high-resolution positron emission scanner Challenges associated with peripheral arterial disease in women.Three-dimensional microwave imaging of realistic numerical breast phantoms via a multiple-frequency inverse scattering technique.Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts.Background parenchymal uptake during molecular breast imaging and associated clinical factors.Breast cancer risk assessment in 64,659 women at a single high-volume mammography clinic.Breast cancer screening in the era of density notification legislation: summary of 2014 Massachusetts experience and suggestion of an evidence-based management algorithm by multi-disciplinary expert panel.Clinical practice guidelines of the French Association for Supportive Care in Cancer and the French Society for Psycho-oncology: refusal of treatment by adults afflicted with cancer.Collimator design for a dedicated molecular breast imaging-guided biopsy system: proof-of-concept.Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status In vivo classification of breast masses using features derived from axial-strain and axial-shear images.Multiple bilateral circumscribed masses at screening breast US: consider annual follow-up Investigating the limit of detectability of a positron emission mammography device: a phantom study.Computer-aided diagnosis of breast DCE-MRI images using bilateral asymmetry of contrast enhancement between two breasts.Patterns of breast magnetic resonance imaging use in community practice Systematic development of an abbreviated protocol for screening breast magnetic resonance imaging The current status of positron emission mammography in breast cancer diagnosis.Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.Adjunctive Breast-Specific Gamma Imaging for Detecting Cancer in Women with Calcifications at Mammography.Utilization of breast cancer screening with magnetic resonance imaging in community practice.Comparison of mammography and ultrasonography findings with pathology results in patients with breast cancer in Birjand, Iran.The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery.Informing Women and Their Physicians about Recommendations for Adjunct Breast MRI Screening: A Cohort Study.

P2860

Q28069645-DEBFFFEB-3166-4596-B397-0CBF1D86F4A4 Q28081408-A1353501-52B3-4122-ACE4-4D817BA0C01D Q28263584-F2056B8C-BA0A-4DAB-93FB-E4F82BD6C425 Q28305001-30157FED-3A6A-4034-979E-2981839C545A Q28741025-B62D736B-AA87-46B0-915B-0CDA5A9F4950 Q30249866-A007283A-2A45-4265-8E38-7ACAEA70561F Q30375416-8E613934-393B-44C3-9D3D-8C264760F2B6 Q30419180-F82790B0-EDEF-449E-94D3-76CFEC3FD7F1 Q30444874-7BA83A20-E0A7-43F7-A67C-784033C4651E Q33863472-3C1CC03D-B360-4799-9467-0421D79F4EF3 Q34040240-19E09C8B-79D7-4904-83F9-C677B28CC43E Q34064948-98FED9C1-FD0E-4924-9081-FC9B4C070AF1 Q34420301-E44ED4DB-D2D8-42C6-8506-58FE4348B4AA Q35527940-49A17FF5-5C3D-478A-8BD7-02CCBAAD91F6 Q35580579-EC62FDBF-F097-42F7-818D-A542D125B33A Q35580614-97919745-1368-414D-AAC9-C5B4453E9CBE Q35682143-7F92C5C7-46CE-42F0-A8D8-2E5457CFC3FD Q36117322-7E6CA5FA-7E05-4E2B-8683-A1D8C2701B58 Q36396510-85BE0479-CE4A-44E7-95FD-4D33ED658EB2 Q36510676-B8B4FFA9-3D65-4621-AC9A-4BD5D1E88387 Q36547262-619CD2A3-6821-4DAD-8707-13C239F1E8AD Q36870883-3BF8BD26-CDC4-4CAD-9C4D-4A879E8695F4 Q37113274-1506BDA9-9928-4B2A-8CB8-D75B2DA70332 Q37489946-2D4135AC-E7B8-4CB9-BF13-5F92B41EC25D Q37522129-D3EEBDEB-7289-4D2B-8F14-1DCDD622072D Q37529123-1066BE15-090B-4543-8B98-A5C12182EFA1 Q37666924-9479E132-3917-40C3-9DFE-EF4E76E32F1B Q38067336-AD6A2E53-BF82-4482-B816-B5350E5053E0 Q38090509-A930217B-09AF-4CEB-A5A3-81DBC0B6E7EC Q38401557-F3A3A41A-093C-45E4-93DB-C4ED75C4F923 Q38618807-B11F61C6-04FC-4ABD-96B5-0502000D8085 Q46186375-43C252AA-88C4-463F-A001-B27A379F3AA1 Q47129709-43A26536-6827-460A-8C7C-AA173F79C1F6 Q50050762-81EE0345-7AE3-4F8B-AEA0-622455E64148 Q50914124-095CD20A-2B59-4CBE-B409-635583B553A6

P2860

Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666.

http://www.wikidata.org/entity/Q33609896

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Reasons women at elevated risk ...... imaging screening: ACRIN 6666.

@ast

Reasons women at elevated risk ...... imaging screening: ACRIN 6666.

@en

type

label

Reasons women at elevated risk ...... imaging screening: ACRIN 6666.

@ast

Reasons women at elevated risk ...... imaging screening: ACRIN 6666.

@en

prefLabel

Reasons women at elevated risk ...... imaging screening: ACRIN 6666.

@ast

Reasons women at elevated risk ...... imaging screening: ACRIN 6666.

@en

P1433

Q33609896-2E725E5B-5294-41F3-95E4-9AFD9367F805

P1476

Q33609896-3CC6899A-020B-450D-95A9-811E06E05167

P2093

Q33609896-047D134D-FDF7-471D-A3F7-1392B0A47A50

Q33609896-17318FB7-A714-40AA-8B28-6886240C75C7

Q33609896-3119DA67-09C2-4D49-86D1-FA82434456A9

Q33609896-35C1E76B-69C6-4168-AF79-A3C3CB87D626

Q33609896-4F21FEC0-1185-4C9F-B2E1-9A246E45F0F2

Q33609896-5DD0B9D7-D839-4F46-B4E4-4E3074EFCB3E

Q33609896-6CCE7FA4-5715-4596-A5DC-EAC78B955DD1

Q33609896-7DB4E1CB-E81D-44D6-B6E2-ED9CC7EA80F1

Q33609896-8E4093DB-8306-4433-A38D-6ECB4D20E3E0

Q33609896-99F707BC-F62E-4E3A-BD07-CAF20B3B66A5

P2860

Q33609896-0697774F-CA77-4135-8C8C-3B1034AB84C2

Q33609896-18D79590-5887-47E8-9668-1916F0CDD20A

Q33609896-3D437C5F-18D5-40A4-9262-C378F14930D0

Q33609896-3EB40CEA-F071-48C4-AD85-01DB95627202

Q33609896-43B474E6-E397-4CA8-B91E-EAA15856D274

Q33609896-46ED4D21-C088-4BA4-869E-D90C69897E80

Q33609896-48570339-1379-4855-AC31-13070DDF8A39

Q33609896-4C7A7D7E-7415-4C59-9D96-6E6771172F6C

Q33609896-530617CC-506E-43E1-81C2-1A316B536C42

Q33609896-5418617A-85A4-4A45-BD94-5F5CFBB6F676

P304

Q33609896-941D1077-3866-4080-BE45-98C0B08726B4

P31

Q33609896-BE354112-4459-4E36-A786-D1E1D8979D1E

P356

Q33609896-B7AF505B-A0F0-485A-8B5F-E4C3E3EAE35A

P407

Q33609896-FDD14059-DBDB-423C-A393-8040137C40D8

P433

Q33609896-2190DCCA-E10E-4BB7-99BE-F69FF8FAADB2

P478

Q33609896-D4212F7B-041F-48BE-ADB1-F87BFBDEB169

P577

Q33609896-3AE6D6CA-F96E-47EA-9E77-E083C6B65931

P5875

Q33609896-EFE3BF82-4CFE-425B-AD64-A821712A58A8

P698

Q33609896-FB8C1630-B54B-497A-9C8F-33A3CF925521

P932

Q33609896-AAEF73B8-5BA0-44D1-A02B-8192855CC1B8

P356

RADIOL.2541090953

P1433

P1476

Reasons women at elevated risk ...... imaging screening: ACRIN 6666.

@en

P2093

Amanda M Adams

http://www.w3.org/2001/XMLSchema#string

Daniel E Lehrer

http://www.w3.org/2001/XMLSchema#string

Ellen B Mendelson

http://www.w3.org/2001/XMLSchema#string

Etta D Pisano

http://www.w3.org/2001/XMLSchema#string

Glenna J Gabrielli

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Blume

http://www.w3.org/2001/XMLSchema#string

Linda Hovanessian Larsen

http://www.w3.org/2001/XMLSchema#string

Mary C Mahoney

http://www.w3.org/2001/XMLSchema#string

Richard G Barr

http://www.w3.org/2001/XMLSchema#string

Roberta A Jong

http://www.w3.org/2001/XMLSchema#string

P2860

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.

Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.

Adult claustrophobia, anxiety and sedation in MRI.

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.

Systematic review: the long-term effects of false-positive mammograms.

Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network (ACRIN) 6666.

P304

79-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.2541090953

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

254

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40767633

http://www.w3.org/2001/XMLSchema#string

P698

20032143

http://www.w3.org/2001/XMLSchema#string

P932

2811274

http://www.w3.org/2001/XMLSchema#string